DecisionPoint Financial’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,750
Closed -$93.6K 652
2025
Q1
$93.6K Hold
2,750
0.03% 57
2024
Q4
$108K Hold
2,750
0.03% 52
2024
Q3
$129K Hold
2,750
0.04% 44
2024
Q2
$158K Hold
2,750
0.05% 41
2024
Q1
$148K Sell
2,750
-48
-2% -$2.59K 0.06% 40
2023
Q4
$175K Buy
2,798
+2,750
+5,729% +$172K 0.08% 34
2023
Q3
$2.18K Buy
+48
New +$2.18K ﹤0.01% 191